Bryosphere Biotechnologies Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 16

Bryosphere Biotechnologies General Information

Description

Developer of a moss-based biomanufacturing platform designed to create bioactive ingredients for skincare. The company's platform offers proprietary moss cultivation, genetic engineering, advanced plant biochemistry techniques, scalable bioprocessing capabilities, and controlled production environments for consistent compound expression, enabling skincare and beauty brands to access quality, plant-derived ingredients that target specific skin concerns while ensuring sustainable and reliable sourcing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1250 Grand Lake Road
  • Nova Scotia
  • Canada
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 1250 Grand Lake Road
  • Nova Scotia
  • Canada

Bryosphere Biotechnologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bryosphere Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Early Stage VC 15-Jun-2026 Completed Generating Revenue
11. Accelerator/Incubator 17-Dec-2025 Completed Product Development
10. Accelerator/Incubator 08-Sep-2025 Completed Product Development
9. Accelerator/Incubator 13-May-2025 Completed Product Development
8. Accelerator/Incubator 01-Jan-2025 Completed Product Development
7. Grant 01-Oct-2024 Completed Product Development
6. Accelerator/Incubator 01-Jan-2024 Completed Product Development
5. Accelerator/Incubator 22-Nov-2023 Completed Product Development
4. Seed Round 11-Sep-2023 Completed Product Development
3. Accelerator/Incubator 18-Jan-2023 Completed Product Development
To view Bryosphere Biotechnologies’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Bryosphere Biotechnologies Patents

Bryosphere Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026036216-A1 Aurone-producing transgenic plants Pending 14-Aug-2024

Bryosphere Biotechnologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bryosphere Biotechnologies Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cape Breton Capital Group Angel Group Minority
HerEco Ventures Venture Capital Minority
Okanagan Women Angel Group Minority
Greenspring Bioinnovation Hub Accelerator/Incubator
Nrth Toronto Accelerator/Incubator
You’re viewing 5 of 16 investors. Get the full list »

Bryosphere Biotechnologies FAQs

  • When was Bryosphere Biotechnologies founded?

    Bryosphere Biotechnologies was founded in 2022.

  • Where is Bryosphere Biotechnologies headquartered?

    Bryosphere Biotechnologies is headquartered in Canada.

  • What is the size of Bryosphere Biotechnologies?

    Bryosphere Biotechnologies has 5 total employees.

  • What industry is Bryosphere Biotechnologies in?

    Bryosphere Biotechnologies’s primary industry is Biotechnology.

  • Is Bryosphere Biotechnologies a private or public company?

    Bryosphere Biotechnologies is a Private company.

  • What is Bryosphere Biotechnologies’s current revenue?

    The current revenue for Bryosphere Biotechnologies is .

  • How much funding has Bryosphere Biotechnologies raised over time?

    Bryosphere Biotechnologies has raised $200K.

  • Who are Bryosphere Biotechnologies’s investors?

    Cape Breton Capital Group, HerEco Ventures, Okanagan Women, Greenspring Bioinnovation Hub, and Nrth Toronto are 5 of 16 investors who have invested in Bryosphere Biotechnologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process